Nitric Oxide Withdrawn Phase 3 Trials for Pulmonary Arterial Hypertension (PAH) Diagnostic

IndicationsStatusPurposePhase
WithdrawnDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT02436512Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide